BACE2 Back

beta-site APP-cleaving enzyme 2

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of BACE2
Cerebral deposition of amyloid beta peptide is an early and critical feature of Alzheimer's disease and a frequent complication of Down syndrome. Amyloid beta peptide is generated by proteolytic cleavage of amyloid precursor protein by 2 proteases, one of which is the protein encoded by this gene. This gene localizes to the 'Down critical region' of chromosome 21. The encoded protein, a member of the peptidase A1 protein family, is a type I integral membrane glycoprotein and aspartic protease. Three transcript variants encoding different isoforms have been described for this gene.

Community Annotation of BACE2 Add / Edit BACE2: Annotations

No community annotations yet for BACE2.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

BACE2 is highly significantly mutated in
(none)
BACE2 is significantly mutated in
(none)
BACE2 is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


• Mutation list for BACE2